USC.edu
Are you a Patient?

Fumito Ito, MD, PhD

Associate Professor of Surgery

Co-Leader of the Translational and Clinical Sciences Research (TACS) Program

Image of Fumito Ito, MD, PhD
Is this your profile? Click to edit
Request an Appointment
Orcid ID CTSI Profile

Awards

  • METAvivor: Translational Research Award, 2021
  • Department of Defense: Investigator Initiated Translational Research Award, 2019
  • Cancer Research Institute: Technology Impact Award, 2019
  • Melanoma Research Alliance: Young Investigator Award, 2015
  • Central Surgical Association Foundation: Turcotte Enrichment Award, 2014
  • American College of Surgeons: Faculty Research Fellowship Award, 2014
  • Society of Thermal Medicine: New Investigator Award, 2010

Publications

  • Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases NPJ Precis Oncol. 2023 Nov 14; 7(1):120. . View in PubMed
  • Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center J Surg Oncol. 2023 Jul; 128(1):9-15. . View in PubMed
  • Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy World J Oncol. 2023 Jun; 14(3):178-187. . View in PubMed
  • Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy Cancer Res Commun. 2023 03; 3(3):510-520. . View in PubMed
  • Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction Cancer Immunol Immunother. 2022 Dec; 71(12):2881-2898. . View in PubMed
  • Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling J Immunother Cancer. 2022 01; 10(1). . View in PubMed
  • CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells Cancer Immunol Immunother. 2022 Jan; 71(1):137-151. . View in PubMed
  • Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model J Immunother Cancer. 2021 12; 9(12). . View in PubMed
  • Position-Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T-Cell Responses Adv Sci (Weinh). 2021 12; 8(24):e2103023. . View in PubMed
  • Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis J Immunother Cancer. 2021 06; 9(6). . View in PubMed
  • In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models J Immunother Cancer. 2021 05; 9(5). . View in PubMed
  • Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer Sci Rep. 2021 11 09; 11(1):21992. . View in PubMed
  • T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors Nat Commun. 2021 03 03; 12(1):1402. . View in PubMed
  • Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression J Immunol. 2021 09 01; 207(5):1298-1309. . View in PubMed
  • Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors Cancer Res. 2021 12 15; 81(24):6183-6195. . View in PubMed
  • Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee J Immunother Cancer. 2020 11; 8(2). . View in PubMed
  • CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment JCI Insight. 2020 04 23; 5(8). . View in PubMed
  • A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells J Immunol. 2020 10 01; 205(7):1867-1877. . View in PubMed
  • Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s Nat Commun. 2020 10 27; 11(1):5415. . View in PubMed
  • In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy Int J Hyperthermia. 2019 11; 36(sup1):22-36. . View in PubMed
  • Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy Surg Oncol Clin N Am. 2019 07; 28(3):489-504. . View in PubMed
  • Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma J Surg Res. 2019 02; 234:343-352. . View in PubMed
  • Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System Cell Rep. 2018 03 20; 22(12):3175-3190. . View in PubMed
  • Emerging role of RNA binding protein UNR/CSDE1 in melanoma J Xiangya Med. 2017 May; 2. . View in PubMed
  • Pre-resectional Radiofrequency Ablation as a Neoadjuvant in situ Tumor Vaccine J Vaccines Vaccin. 2016 Apr; 7(2). . View in PubMed
  • Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory Cancer Res. 2016 06 15; 76(12):3473-83. . View in PubMed
  • Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells Stem Cells Int. 2016; 2016:8394960. . View in PubMed
  • Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes J Vis Exp. 2016 11 11; (117). . View in PubMed
  • Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10 Eur J Immunol. 2015 Apr; 45(4):999-1009. . View in PubMed
  • Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer PLoS One. 2015; 10(11):e0143370. . View in PubMed
  • Cancer immunotherapy: current status and future directions Surg Oncol Clin N Am. 2013 Oct; 22(4):765-83. . View in PubMed
  • Water: a simple solution for tumor spillage Ann Surg Oncol. 2011 Aug; 18(8):2357-63. . View in PubMed
  • Hilar cholangiocarcinoma: current management Ann Surg. 2009 Aug; 250(2):210-8. . View in PubMed
  • Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence Ann Surg. 2008 Aug; 248(2):273-9. . View in PubMed
  • Transabdominal preperitoneal robotic inguinal hernia repair J Laparoendosc Adv Surg Tech A. 2008 Jun; 18(3):397-9. . View in PubMed
  • The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing Ann Surg. 2007 Jun; 245(6):959-63. . View in PubMed
  • Robotic foregut surgery Int J Med Robot. 2006 Dec; 2(4):287-92. . View in PubMed
  • Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines Cancer Res. 2004 Nov 15; 64(22):8411-9. . View in PubMed
  • Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control the efficiency of cytotoxic T cell priming Microbiol Immunol. 2004; 48(3):211-9. . View in PubMed
  • Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration Cancer Res. 2003 Dec 01; 63(23):8466-75. . View in PubMed
  • Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy Cancer Res. 2003 May 15; 63(10):2546-52. . View in PubMed
  • Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine model J Immunother. 2003 May-Jun; 26(3):222-33. . View in PubMed

Similar People